{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T16:49:04Z","timestamp":1791910144981,"version":"4.3.4"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T00:00:00Z","timestamp":1783987200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T00:00:00Z","timestamp":1791849600000},"content-version":"vor","delay-in-days":91,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Infect Agents Cancer"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Despite major advances in antiretroviral therapy (ART), HIV-associated malignancies remain a significant cause of morbidity and mortality in low- and middle-income countries. In Tunisia, data on AIDS-defining cancers (ADCs) and non\u2013AIDS-defining cancers (NADCs) among people living with HIV (PLWH) remain scarce.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a descriptive retrospective cohort study over a 30-year period (1994\u20132024) at Farhat Hached University Hospital, Sousse, Tunisia. All PLWH who developed at least one malignant neoplasm were included. Epidemiological, clinical, immunovirological, pathological, and outcome data were retrospectively collected and analyzed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Among 655 PLWH followed during the study period, 25 patients with a median age of 36 years developed malignancies, representing 3.8% of all PLWH. 27 malignancies were identified with 2 patients developing 2 distinct malignancies: a Kaposi sarcoma (KS) and a Non-AIDS-defining cancer (NADC). AIDS-defining cancers (ADC) predominated (81.5%), mainly KS (44.4%) and non-Hodgkin lymphoma (33.3%), while NADCs accounted for 18.5%. Cancer and\n                      <jats:italic>HIV diagnoses<\/jats:italic>\n                      were concomitant in 56%\n                      <jats:italic>of patients (<\/jats:italic>\n                      <jats:italic>n<\/jats:italic>\n                      <jats:italic>\u2009=\u200914)<\/jats:italic>\n                      and 92% of malignancies occurred within the first year following HIV diagnosis. Most patients presented with advanced immunodeficiency, with median CD4 counts at tumor diagnosis of 73 cells\/mm\u00b3 for ADCs and 57 cells\/mm\u00b3 for NADCs. Median overall survival was 1.9 years for ADCs and 3.7 years for NADCs.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>In this North African cohort, HIV-associated malignancies were predominantly AIDS-defining cancer and affected young adults with advanced immunosuppression, reflecting late HIV diagnosis for PLWH developing malignancies. Beyond strengthening early HIV testing and timely ART initiation, targeted patient education focusing on high-risk behaviors, along with efforts to reduce HIV-related stigma, are essential components to improve cancer prevention, early diagnosis, and outcomes among PLWH in resource-limited settings.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13027-026-00779-y","type":"journal-article","created":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T13:36:08Z","timestamp":1784036168000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["HIV-associated malignancies in Tunisia: a 30-year retrospective cohort study from a North African perspective"],"prefix":"10.1186","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-1987-6121","authenticated-orcid":false,"given":"Sarra","family":"Yacoub","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manel","family":"Ben Selma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Souha","family":"Ghachem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariem","family":"Ben Ticha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hela","family":"Knani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariem","family":"Garma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taghrid","family":"Tlili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Safouene","family":"Frini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Badreddine","family":"Sriha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wissem","family":"Hachfi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,14]]},"reference":[{"key":"779_CR1","unstructured":"UNAIDS. Middle East and North Africa regional profile \u2014 2024 global AIDS update: The urgency of now: AIDS at a Crossroads. Geneva: UNAIDS. 2024. Available from: https:\/\/www.unaids.org\/sites\/default\/files\/media_asset\/2024-unaids-global-aids-update-mena_en.pdf."},{"key":"779_CR2","unstructured":"UNAIDS, AIDSinfo. Epidemic & Response [Internet]. Geneva: UNAIDS; 2024 [cited 2026 Jun 10]. Available from: https:\/\/aidsinfo.unaids.org\/."},{"issue":"9","key":"779_CR3","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1093\/jnci\/djr076","volume":"103","author":"MS Shiels","year":"2011","unstructured":"Shiels MS, Pfeiffer RM, Gail MH, Hall HI, Li J, Chaturvedi AK, et al. Cancer burden in the HIV-infected population in the United States. J Natl Cancer Inst. 2011;103(9):753\u201362. https:\/\/doi.org\/10.1093\/jnci\/djr076","journal-title":"J Natl Cancer Inst"},{"issue":"10","key":"779_CR4","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1097\/QAD.0b013e328353f38e","volume":"26","author":"EP Simard","year":"2012","unstructured":"Simard EP, Pfeiffer RM, Engels EA. Mortality due to cancer among people with AIDS: a novel approach using registry-linkage data and population attributable risk methods. AIDS. 2012;26(10):1311\u20138. https:\/\/doi.org\/10.1097\/QAD.0b013e328353f38e.","journal-title":"AIDS"},{"issue":"1","key":"779_CR5","doi-asserted-by":"publisher","first-page":"70","DOI":"10.3390\/cancers16010070","volume":"16","author":"AM Cattelan","year":"2023","unstructured":"Cattelan AM, Mazzitelli M, Presa N, Cozzolino C, Sasset L, Leoni D, et al. Changing prevalence of AIDS and non-AIDS-defining cancers in an incident cohort of people living with HIV over 28 years. Cancers (Basel). 2023;16(1):70. https:\/\/doi.org\/10.3390\/cancers16010070","journal-title":"Cancers (Basel)"},{"issue":"4 Suppl","key":"779_CR6","doi-asserted-by":"publisher","first-page":"S149","DOI":"10.1016\/j.medmal.2018.04.374","volume":"48","author":"A Ghrabi","year":"2018","unstructured":"Ghrabi A, Ammari L, Berriche A, Aissa S, Kanoun F, Harrabi H, et al. Cancers classant sida et infection par le VIH: exp\u00e9rience tunisienne. Med Mal Infect. 2018;48(4 Suppl):S149. https:\/\/doi.org\/10.1016\/j.medmal.2018.04.374","journal-title":"Med Mal Infect"},{"issue":"2","key":"779_CR7","doi-asserted-by":"publisher","first-page":"576","DOI":"10.4103\/0973-1482.179521","volume":"12","author":"K Chaabna","year":"2016","unstructured":"Chaabna K, Newton R, Vanhems P, Laouar M, Forman D, Boudiaf Z, et al. Cancer incidence and all-cause mortality in HIV-positive patients in north-eastern Algeria before and during the era of highly active antiretroviral therapy. J Cancer Res Ther. 2016;12(2):576\u201382. https:\/\/doi.org\/10.4103\/0973-1482.179521","journal-title":"J Cancer Res Ther"},{"issue":"7","key":"779_CR8","doi-asserted-by":"publisher","first-page":"507","DOI":"10.7326\/M14-2768","volume":"163","author":"MJ Silverberg","year":"2015","unstructured":"Silverberg MJ, Lau B, Achenbach CJ, Jing Y, Althoff KN, D\u2019Souza G, et al. Cumulative incidence of cancer among HIV-infected individuals in North America. Ann Intern Med. 2015;163(7):507\u201318. https:\/\/doi.org\/10.7326\/M14-2768","journal-title":"Ann Intern Med"},{"key":"779_CR9","doi-asserted-by":"publisher","first-page":"105","DOI":"10.11604\/pamj.2016.25.105.9748","volume":"25","author":"J Chelli","year":"2016","unstructured":"Chelli J, Bellazreg F, Aouem A, Hattab Z, Mesmia H, Lasfar NB, et al. Causes de d\u00e9c\u00e8s des patients infect\u00e9s par le VIH dans le Centre tunisien. Pan Afr Med J. 2016;25:105. https:\/\/doi.org\/10.11604\/pamj.2016.25.105.9748","journal-title":"Pan Afr Med J"},{"issue":"1","key":"779_CR10","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1097\/COH.0000000000000329","volume":"12","author":"L Chinula","year":"2017","unstructured":"Chinula L, Moses A, Gopal S. HIV-associated malignancies in sub-Saharan Africa: progress, challenges, opportunities. CurrOpin HIV AIDS. 2017;12(1):89\u201395. https:\/\/doi.org\/10.1097\/COH.0000000000000329","journal-title":"CurrOpin HIV AIDS"},{"issue":"5 Suppl","key":"779_CR11","doi-asserted-by":"publisher","first-page":"S138","DOI":"10.1002\/hep.22883","volume":"49","author":"CL Thio","year":"2009","unstructured":"Thio CL. Hepatitis B and human immunodeficiency virus coinfection. Hepatology. 2009;49(5 Suppl):S138\u201345. https:\/\/doi.org\/10.1002\/hep.22883","journal-title":"Hepatology"},{"issue":"4","key":"779_CR12","doi-asserted-by":"publisher","first-page":"dju503","DOI":"10.1093\/jnci\/dju503","volume":"107","author":"HA Robbins","year":"2015","unstructured":"Robbins HA, Pfeiffer RM, Shiels MS, Li J, Hall HI, Engels EA. Excess cancers among HIV-infected people in the United States. J Natl Cancer Inst. 2015;107(4):dju503. https:\/\/doi.org\/10.1093\/jnci\/dju503","journal-title":"J Natl Cancer Inst"},{"issue":"12","key":"779_CR13","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1016\/S1470-2045(09)70282-7","volume":"10","author":"M Guiguet","year":"2009","unstructured":"Guiguet M, Bou\u00e9 F, Cadranel J, Lang JM, Rosenthal E, Costagliola D, Clinical Epidemiology Group of the FHDH-ANRS CO4 cohort. Effect of immunodeficiency, HIV viral load, and antiretroviral therapy on the risk of individual malignancies (FHDH-ANRS CO4): a prospective cohort study. Lancet Oncol. 2009;10(12):1152\u20139. https:\/\/doi.org\/10.1016\/S1470-2045(09)70282-7","journal-title":"Lancet Oncol"},{"issue":"6","key":"779_CR14","first-page":"494","volume":"85","author":"AS Dhrif","year":"2007","unstructured":"Dhrif AS, Kilani B, Ammari L, Kanoun F, Tiouri H, Ben Chaaben T. AIDS-associated Kaposi\u2019s sarcoma: 22 cases. Tunis Med. 2007;85(6):494\u20139. PMID: 17644904.","journal-title":"Tunis Med"},{"issue":"18","key":"779_CR15","doi-asserted-by":"publisher","first-page":"2881","DOI":"10.1097\/QAD.0b013e32833f9fb8","volume":"24","author":"NF Crum-Cianflone","year":"2010","unstructured":"Crum-Cianflone NF, Hullsiek KH, Ganesan A, Weintrob A, Okulicz JF, Agan BK. Is Kaposi\u2019s sarcoma occurring at higher CD4 counts over the course of the HIV epidemic? AIDS. 2010;24(18):2881\u20133. https:\/\/doi.org\/10.1097\/QAD.0b013e32833f9fb8","journal-title":"AIDS"},{"issue":"3","key":"779_CR16","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/0190-9622(93)70057-Z","volume":"28","author":"JW Tappero","year":"1993","unstructured":"Tappero JW, Conant MA, Wolfe SF, Berger TG. Kaposi\u2019s sarcoma: epidemiology, pathogenesis, histology, clinical spectrum, staging criteria and therapy. J Am Acad Dermatol. 1993;28(3):371\u201395. https:\/\/doi.org\/10.1016\/0190-9622(93)70057-Z","journal-title":"J Am Acad Dermatol"},{"issue":"11","key":"779_CR17","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1093\/jnci\/djq134","volume":"102","author":"S Lodi","year":"2010","unstructured":"Lodi S, Guiguet M, Costagliola D, Fisher M, de Luca A, Porter K. Kaposi sarcoma incidence and survival among HIV-infected homosexual men after HIV seroconversion. J Natl Cancer Inst. 2010;102(11):784\u201392. https:\/\/doi.org\/10.1093\/jnci\/djq134","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"779_CR18","doi-asserted-by":"publisher","first-page":"73","DOI":"10.4103\/IJPM.IJPM_452_17","volume":"62","author":"R Sampath","year":"2019","unstructured":"Sampath R, Manipadam MT, Nair S, Viswabandya A, Zachariah A. HIV-associated lymphoma: a 5-year clinicopathologic study from India. Indian J Pathol Microbiol. 2019;62(1):73\u20138. https:\/\/doi.org\/10.4103\/IJPM.IJPM_452_17","journal-title":"Indian J Pathol Microbiol"},{"issue":"17","key":"779_CR19","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1182\/blood-2018-01-791400","volume":"134","author":"A Noy","year":"2019","unstructured":"Noy A. Optimizing treatment of HIV-associated lymphoma. Blood. 2019;134(17):1385\u201394. https:\/\/doi.org\/10.1182\/blood-2018-01-791400","journal-title":"Blood"},{"issue":"1","key":"779_CR20","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1002\/ijc.28963","volume":"136","author":"L Alemany","year":"2015","unstructured":"Alemany L, Saunier M, Alvarado I, Quir\u00f3s B, Salmeron J, Shin HR, et al. HPV DNA prevalence and type distribution in anal carcinomas worldwide. Int J Cancer. 2015;136(1):98\u2013107. https:\/\/doi.org\/10.1002\/ijc.28963","journal-title":"Int J Cancer"}],"container-title":["Infectious Agents and Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13027-026-00779-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13027-026-00779-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13027-026-00779-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T16:06:01Z","timestamp":1791907561000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13027-026-00779-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,14]]},"references-count":20,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["779"],"URL":"https:\/\/doi.org\/10.1186\/s13027-026-00779-y","relation":{},"ISSN":["1750-9378"],"issn-type":[{"value":"1750-9378","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,14]]},"assertion":[{"value":"8 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Ethics Committee of the Faculty of Medicine of Sousse (Tunisia) in May 2024. Due to the retrospective nature of the study, the requirement for informed consent was waived by the Ethics Committee. Medical confidentiality and patient anonymity were strictly maintained. The study was conducted in accordance with the principles of the Declaration of Helsinki.","order":1,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"67"}}